annb0t
Top 20
Stereotaxis, Inc. STXS, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, recently received its first order for the latest generation robotic system, GenesisX, from a pioneering European hospital.
The latest development is in line with Stereotaxisâ focus on broadening the adoption of robotics across endovascular interventions.
STXS Stock Likely to Gain From the Development
Since the announcement, STXS stock has edged 5.1% to $2.37 at last ...
>>> Read more: STXS Stock Gains Following the First Order for its GenesisX
The latest development is in line with Stereotaxisâ focus on broadening the adoption of robotics across endovascular interventions.
STXS Stock Likely to Gain From the Development
Since the announcement, STXS stock has edged 5.1% to $2.37 at last ...
>>> Read more: STXS Stock Gains Following the First Order for its GenesisX
